home · filing · 0001493152-24-033756
8-K filed August 23, 2024, 7:59 PM ET
ticker TVGN
CIK 0001860871
other material
confidence high
sentiment neutral
materiality 0.60
Tevogen Bio raises $6M via Series C Preferred; director Suren Ajjarapu resigns
Tevogen Bio Holdings Inc.
Sold 600 shares of Series C Preferred at $10,000 each for $6.0M aggregate to The Patel Family, LLP.
Series C carries 7.5% annual cumulative dividend, convertible after 6 months at VWAP floor $0.6172.
Conversion subject to 9.99% beneficial ownership limitation; pre-funded warrants issued if exceeded.
Director Suren Ajjarapu resigned effective August 21, 2024, with no disagreement with the company.
Proceeds from unregistered sale used for general corporate purposes; stock not registered under Securities Act.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2024-08-21
Filed August 23, 2024, 7:59 PM ET
On August 20, 2024, Suren Ajjarapu gave notice of his resignation from service as a director of the Company, effective August 21, 2024.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Suren Ajjarapu resigned as Director at Tevogen Bio Holdings Inc..
Action resigned
Role Director
Exact text from the filing
On August 20, 2024, Suren Ajjarapu gave notice of his resignation from service as a director of the Company, effective August 21, 2024.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-24-033756
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.